Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3Gastrointestinal 2Thoracic 1Sarcoma 1CNS 1

Conditions

Financial Stress 1Bone Neoplasms 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 32Cyclophosphamide 27Doxorubicin 24Temozolomide 23Biopsy 23pembrolizumab 22Radiotherapy 19X-Rays 18Radiation 18Nivolumab 16Vincristine 14Irinotecan 13Phantoms, Imaging 12Ifosfamide 12Gemcitabine 11fludarabine 10cabozantinib 10atezolizumab 10Ipilimumab 10Bevacizumab 9liposomal doxorubicin 8Paclitaxel 8Immunoglobulin G 8Surgical Procedures, Operative 7Dactinomycin 7Carboplatin 7palbociclib 6olaparib 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Data Collection × Sarcoma × 90 days × Clear all
NCT07215611 2026-04-30

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Sarcoma

Financial Stress, Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡